Ultragenyx Pharmaceutical | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Kyowa Hakko Kirin JPY 850.81B 15.56B 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
Moderna USD 10.9B 1.03B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Ultragenyx Pharmaceutical Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.